Amos Anderson
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.2% of the total across 227 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,420 and has fallen 90.4% since, to $136 in 2025.
Across 227 payments — averaging $24.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$813
- Cook Medical LLC$748
- Boston Scientific$733
- Astellas Pharma US Inc$699
- Pfizer$293
- AbbVie$288
- plus $2K from 31 others
What the payments were for
- Food & beverage$5,25095%
- Education$2655%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 14 | $813 |
| Cook Medical LLC | 9 | $748 |
| Boston Scientific | 9 | $733 |
| Astellas Pharma US Inc | 51 | $699 |
| Pfizer | 21 | $293 |
| AbbVie(2 entities) | 15 | $288 |
| Teleflex LLC | 3 | $214 |
| Bayer | 13 | $209 |
| Johnson & Johnson | 5 | $147 |
| Endo Pharmaceuticals Inc. | 9 | $139 |
| Blue Earth Diagnostics | 5 | $125 |
| Myovant Sciences Inc. | 8 | $118 |
| Dendreon Pharmaceuticals LLC | 5 | $114 |
| Urogen Pharma, Inc. | 5 | $90 |
| Axonics, Inc. | 2 | $70 |
| Travere Therapeutics, Inc. | 17 | $67 |
| Baxter Healthcare | 1 | $58 |
| Coloplast | 3 | $49 |
| Antares Pharma, Inc. | 3 | $48 |
| Amgen | 3 | $47 |
| Myriad Genetic Laboratories, Inc. | 3 | $46 |
| Merck | 2 | $40 |
| Procept Biorobotics Corporation | 2 | $40 |
| Rochester Medical Corporation | 2 | $38 |
| Alnylam Pharmaceuticals Inc. | 2 | $35 |
| Palette Life Sciences, Inc. | 1 | $32 |
| Novartis | 2 | $32 |
| AstraZeneca | 2 | $32 |
| Urovant Sciences Inc | 2 | $31 |
| Tolmar Pharmaceuticals, Inc. | 1 | $20 |
| Accord Healthcare, Inc. | 1 | $20 |
| Therapeuticsmd, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| 180 Medical, Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $14 |
| Angiodynamics, Inc. | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$286
- GENERAL - THERAPIES$229
- Cook$206
- SpaceOAR VUE System - 10mL$127
- RESONANCE$127
- FIBER DUST$126
- AMS 700 CXR RTE KIT$123
- Barrigel$121
How this compares
$5,516 in reported general payments places this provider in the 55th percentile of 369 urology providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 14 | $123 |
Paid to pharmacies, not to this prescriber.
Other urology in Macon
- Joshua PerkelMacon$36K
- James LewisMacon$29K
- Brian GearyMacon$27K
- Joseph BearMacon$14K
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Daniel CanterDecatur$329K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.